Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 793 to 804 of 808 entries
Sorted by: Best Match Show Resources per page
Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series.

Clinical case reports

Ciddhavaduta DL, Kalaiselvan V, Midde ML, Baloju D.
PMID: 33363758
Clin Case Rep. 2020 Jul 28;8(12):2452-2456. doi: 10.1002/ccr3.3145. eCollection 2020 Dec.

SJS-TEN is life-threatening autoimmune disorder triggered due to drugs such as analgesics, antibiotics, anticonvulsants, and antipsychotics. This report provides awareness to the Clinicians regarding prescription of drugs which cause SJS-TEN. Among young females of 20-40 years, screening for previous...

Cite
Ciddhavaduta DL, Kalaiselvan V, Midde ML, et al. Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series. Clin Case Rep. 2020;8(12):2452-2456doi: 10.1002/ccr3.3145.
Ciddhavaduta, D. L., Kalaiselvan, V., Midde, M. L., & Baloju, D. (2020). Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series. Clinical case reports, 8(12), 2452-2456. https://doi.org/10.1002/ccr3.3145
Ciddhavaduta, Deepa Latha, et al. "Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series." Clinical case reports vol. 8,12 (2020): 2452-2456. doi: https://doi.org/10.1002/ccr3.3145
Ciddhavaduta DL, Kalaiselvan V, Midde ML, Baloju D. Analysis of severity and preventability in patients of-Toxic epidermal necrolysis-A case series. Clin Case Rep. 2020 Jul 28;8(12):2452-2456. doi: 10.1002/ccr3.3145. eCollection 2020 Dec. PMID: 33363758; PMCID: PMC7752467.
Copy Download .nbib Format: NLM
Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review.

Frontiers in genetics

Gomes JDA, Olstad EW, Kowalski TW, Gervin K, Vianna FSL, Schüler-Faccini L, Nordeng HME.
PMID: 33981330
Front Genet. 2021 Apr 27;12:645555. doi: 10.3389/fgene.2021.645555. eCollection 2021.

Since the 1960s, drugs have been known to cause teratogenic effects in humans. Such teratogenicity has been postulated to be influenced by genetics. The aim of this review was to provide an overview of the current knowledge on genetic...

Cite
Gomes JDA, Olstad EW, Kowalski TW, et al. Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review. Front Genet. 2021;12:645555doi: 10.3389/fgene.2021.645555.
Gomes, J. D. A., Olstad, E. W., Kowalski, T. W., Gervin, K., Vianna, F. S. L., Schüler-Faccini, L., & Nordeng, H. M. E. (2021). Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review. Frontiers in genetics, 12645555. https://doi.org/10.3389/fgene.2021.645555
Gomes, Julia do Amaral, et al. "Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review." Frontiers in genetics vol. 12 (2021): 645555. doi: https://doi.org/10.3389/fgene.2021.645555
Gomes JDA, Olstad EW, Kowalski TW, Gervin K, Vianna FSL, Schüler-Faccini L, Nordeng HME. Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review. Front Genet. 2021 Apr 27;12:645555. doi: 10.3389/fgene.2021.645555. eCollection 2021. PMID: 33981330; PMCID: PMC8107476.
Copy Download .nbib Format: NLM
An experimental study on the effect of four pediatric drug types on color stability in different tooth-colored restorative materials.

Dental research journal

Faghihi T, Heidarzadeh Z, Jafari K, Farhoudi I, Hekmatfar S.
PMID: 34760066
Dent Res J (Isfahan). 2021 Sep 25;18:75. doi: 10.4103/1735-3327.326648. eCollection 2021.

BACKGROUND: One of the drawbacks of tooth-colored dental restorations is their discoloration over time. The present study aimed to determine the effect of four categories of pediatric medications, including analgesics, antibiotics, anticonvulsants, and multivitamins, on two types of tooth-colored...

Cite
Faghihi T, Heidarzadeh Z, Jafari K, et al. An experimental study on the effect of four pediatric drug types on color stability in different tooth-colored restorative materials. Dent Res J (Isfahan). 2021;18:75doi: 10.4103/1735-3327.326648.
Faghihi, T., Heidarzadeh, Z., Jafari, K., Farhoudi, I., & Hekmatfar, S. (2021). An experimental study on the effect of four pediatric drug types on color stability in different tooth-colored restorative materials. Dental research journal, 1875. https://doi.org/10.4103/1735-3327.326648
Faghihi, Taraneh, et al. "An experimental study on the effect of four pediatric drug types on color stability in different tooth-colored restorative materials." Dental research journal vol. 18 (2021): 75. doi: https://doi.org/10.4103/1735-3327.326648
Faghihi T, Heidarzadeh Z, Jafari K, Farhoudi I, Hekmatfar S. An experimental study on the effect of four pediatric drug types on color stability in different tooth-colored restorative materials. Dent Res J (Isfahan). 2021 Sep 25;18:75. doi: 10.4103/1735-3327.326648. eCollection 2021. PMID: 34760066; PMCID: PMC8543097.
Copy Download .nbib Format: NLM
Neurological manifestations due to dengue virus infection in children: clinical follow-up.

Pathogens and global health

Bentes AA, Maia De Castro Romanelli R, Crispim APC, Marinho PES, Loutfi KS, Araujo ST, Campos E Silva LM, Guedes I, Martins Alvarenga A, Santos MA, Geessien Kroon E.
PMID: 34223795
Pathog Glob Health. 2021 Oct-Dec;115(7):476-482. doi: 10.1080/20477724.2021.1942680. Epub 2021 Jul 05.

The aim was to assess neurological complications in children with an invasive neurological disease by dengue virus (DENV) and the time to resolve symptoms after hospital discharge. A prospective study was conducted at a referral hospital for infectious diseases...

Cite
Bentes AA, Maia De Castro Romanelli R, Crispim APC, et al. Neurological manifestations due to dengue virus infection in children: clinical follow-up. Pathog Glob Health. 2021;115(7):476-482doi: 10.1080/20477724.2021.1942680.
Bentes, A. A., Maia De Castro Romanelli, R., Crispim, A. P. C., Marinho, P. E. S., Loutfi, K. S., Araujo, S. T., Campos E Silva, L. M., Guedes, I., Martins Alvarenga, A., Santos, M. A., & Geessien Kroon, E. (2021). Neurological manifestations due to dengue virus infection in children: clinical follow-up. Pathogens and global health, 115(7), 476-482. https://doi.org/10.1080/20477724.2021.1942680
Bentes, Aline Almeida, et al. "Neurological manifestations due to dengue virus infection in children: clinical follow-up." Pathogens and global health vol. 115,7 (2021): 476-482. doi: https://doi.org/10.1080/20477724.2021.1942680
Bentes AA, Maia De Castro Romanelli R, Crispim APC, Marinho PES, Loutfi KS, Araujo ST, Campos E Silva LM, Guedes I, Martins Alvarenga A, Santos MA, Geessien Kroon E. Neurological manifestations due to dengue virus infection in children: clinical follow-up. Pathog Glob Health. 2021 Oct-Dec;115(7):476-482. doi: 10.1080/20477724.2021.1942680. Epub 2021 Jul 05. PMID: 34223795; PMCID: PMC8635603.
Copy Download .nbib Format: NLM
Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib.

Cureus

Shanthosh Kumar S, Nagesh VK, Sivakolundu KP, Ali B, Sange I.
PMID: 34660133
Cureus. 2021 Sep 13;13(9):e17944. doi: 10.7759/cureus.17944. eCollection 2021 Sep.

Posterior reversible encephalopathy syndrome (PRES) is a reversible neurological syndrome characterized by headache, seizures, altered mental status, and visual abnormalities, in association with the characteristic bilateral white matter abnormalities in the posterior cerebral hemispheres. As the name suggests, it...

Cite
Shanthosh Kumar S, Nagesh VK, Sivakolundu KP, et al. Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib. Cureus. 2021;13(9):e17944doi: 10.7759/cureus.17944.
Shanthosh Kumar, S., Nagesh, V. K., Sivakolundu, K. P., Ali, B., & Sange, I. (2021). Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib. Cureus, 13(9), e17944. https://doi.org/10.7759/cureus.17944
Shanthosh Kumar, Sandhya, et al. "Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib." Cureus vol. 13,9 (2021): e17944. doi: https://doi.org/10.7759/cureus.17944
Shanthosh Kumar S, Nagesh VK, Sivakolundu KP, Ali B, Sange I. Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient With Primary Myelofibrosis on Ruxolitinib. Cureus. 2021 Sep 13;13(9):e17944. doi: 10.7759/cureus.17944. eCollection 2021 Sep. PMID: 34660133; PMCID: PMC8513730.
Copy Download .nbib Format: NLM
The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.

Frontiers in physiology

Kim S, Jo CH, Kim GH.
PMID: 34955900
Front Physiol. 2021 Dec 10;12:797039. doi: 10.3389/fphys.2021.797039. eCollection 2021.

Hyponatremia is frequently encountered in clinical practice and usually induced by renal water retention. Many medications are considered to be among the various causes of hyponatremia, because they either stimulate the release of arginine vasopressin (AVP) or potentiate its...

Cite
Kim S, Jo CH, Kim GH. The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Front Physiol. 2021;12:797039doi: 10.3389/fphys.2021.797039.
Kim, S., Jo, C. H., & Kim, G. H. (2021). The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Frontiers in physiology, 12797039. https://doi.org/10.3389/fphys.2021.797039
Kim, Sua, et al. "The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia." Frontiers in physiology vol. 12 (2021): 797039. doi: https://doi.org/10.3389/fphys.2021.797039
Kim S, Jo CH, Kim GH. The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia. Front Physiol. 2021 Dec 10;12:797039. doi: 10.3389/fphys.2021.797039. eCollection 2021. PMID: 34955900; PMCID: PMC8703040.
Copy Download .nbib Format: NLM
Individual vulnerabilities to psychosis after antiepileptic drug administration.

BMJ neurology open

Akanuma N, Adachi N, Fenwick P, Ito M, Okazaki M, Hara K, Ishii R, Sekimoto M, Kato M, Onuma T.
PMID: 33681791
BMJ Neurol Open. 2020 Aug 27;2(2):e000036. doi: 10.1136/bmjno-2019-000036. eCollection 2020.

BACKGROUND: Psychosis often develops after the administration of antiepileptic drugs (AEDs) in patients with epilepsy. However, the individual vulnerability and clinical condition of such patients have been rarely scrutinised. We investigated the effect of individually consistent (trait-dependent) and inconsistent...

Cite
Akanuma N, Adachi N, Fenwick P, et al. Individual vulnerabilities to psychosis after antiepileptic drug administration. BMJ Neurol Open. 2020;2(2):e000036doi: 10.1136/bmjno-2019-000036.
Akanuma, N., Adachi, N., Fenwick, P., Ito, M., Okazaki, M., Hara, K., Ishii, R., Sekimoto, M., Kato, M., & Onuma, T. (2020). Individual vulnerabilities to psychosis after antiepileptic drug administration. BMJ neurology open, 2(2), e000036. https://doi.org/10.1136/bmjno-2019-000036
Akanuma, Nozomi, et al. "Individual vulnerabilities to psychosis after antiepileptic drug administration." BMJ neurology open vol. 2,2 (2020): e000036. doi: https://doi.org/10.1136/bmjno-2019-000036
Akanuma N, Adachi N, Fenwick P, Ito M, Okazaki M, Hara K, Ishii R, Sekimoto M, Kato M, Onuma T. Individual vulnerabilities to psychosis after antiepileptic drug administration. BMJ Neurol Open. 2020 Aug 27;2(2):e000036. doi: 10.1136/bmjno-2019-000036. eCollection 2020. PMID: 33681791; PMCID: PMC7903174.
Copy Download .nbib Format: NLM
Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies.

Journal of diabetes and metabolic disorders

Arora K, Tomar PC, Mohan V.
PMID: 34900824
J Diabetes Metab Disord. 2021 Jun 25;20(2):1773-1784. doi: 10.1007/s40200-021-00830-2. eCollection 2021 Dec.

The global pandemic of prediabetes and diabetes has led to a severe corresponding complication of these disorders. Neuropathy is one of the most prevalent complication of diabetes is, affecting blood supply of the peripheral nervous system that may eventually...

Cite
Arora K, Tomar PC, Mohan V. Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies. J Diabetes Metab Disord. 2021;20(2):1773-1784doi: 10.1007/s40200-021-00830-2.
Arora, K., Tomar, P. C., & Mohan, V. (2021). Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies. Journal of diabetes and metabolic disorders, 20(2), 1773-1784. https://doi.org/10.1007/s40200-021-00830-2
Arora, Komal, et al. "Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies." Journal of diabetes and metabolic disorders vol. 20,2 (2021): 1773-1784. doi: https://doi.org/10.1007/s40200-021-00830-2
Arora K, Tomar PC, Mohan V. Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies. J Diabetes Metab Disord. 2021 Jun 25;20(2):1773-1784. doi: 10.1007/s40200-021-00830-2. eCollection 2021 Dec. PMID: 34900824; PMCID: PMC8630252.
Copy Download .nbib Format: NLM
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability.

Metabolic brain disease

Singh T, Mishra A, Goel RK.
PMID: 34427842
Metab Brain Dis. 2021 Oct;36(7):1573-1590. doi: 10.1007/s11011-021-00823-3. Epub 2021 Aug 24.

Pentylenetetrazole (PTZ)-induced seizure is one of the gold standard mouse models for rapid evaluation of novel anticonvulsants. Synchronically, PTZ induced kindling in mice is also a simple and well accepted model of chronic epilepsy. PTZ kindling has been explored...

Cite
Singh T, Mishra A, Goel RK. PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. 2021;36(7):1573-1590doi: 10.1007/s11011-021-00823-3.
Singh, T., Mishra, A., & Goel, R. K. (2021). PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metabolic brain disease, 36(7), 1573-1590. https://doi.org/10.1007/s11011-021-00823-3
Singh, Tanveer, et al. "PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability." Metabolic brain disease vol. 36,7 (2021): 1573-1590. doi: https://doi.org/10.1007/s11011-021-00823-3
Singh T, Mishra A, Goel RK. PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. 2021 Oct;36(7):1573-1590. doi: 10.1007/s11011-021-00823-3. Epub 2021 Aug 24. PMID: 34427842.
Copy Download .nbib Format: NLM
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation.

Annals of hepato-biliary-pancreatic surgery

Cho A, Lee JM, Hong K, Han ES, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS.
PMID: 34845130
Ann Hepatobiliary Pancreat Surg. 2021 Nov 30;25(4):551-555. doi: 10.14701/ahbps.2021.25.4.551.

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare delayed-type hypersensitivity reaction that causes skin abnormalities and mucosal involvement of the entire body. This is a case report of DRESS occurring in a liver transplantation recipient...

Cite
Cho A, Lee JM, Hong K, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation. Ann Hepatobiliary Pancreat Surg. 2021;25(4):551-555doi: 10.14701/ahbps.2021.25.4.551.
Cho, A., Lee, J. M., Hong, K., Han, E. S., Hong, S. K., Choi, Y., Yi, N. J., Lee, K. W., & Suh, K. S. (2021). Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation. Annals of hepato-biliary-pancreatic surgery, 25(4), 551-555. https://doi.org/10.14701/ahbps.2021.25.4.551
Cho, Ara, et al. "Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation." Annals of hepato-biliary-pancreatic surgery vol. 25,4 (2021): 551-555. doi: https://doi.org/10.14701/ahbps.2021.25.4.551
Cho A, Lee JM, Hong K, Han ES, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation. Ann Hepatobiliary Pancreat Surg. 2021 Nov 30;25(4):551-555. doi: 10.14701/ahbps.2021.25.4.551. PMID: 34845130; PMCID: PMC8639316.
Copy Download .nbib Format: NLM
Toxicity Profile of Procarbazine Lomustine and Vincristine Chemotherapy in Low-Grade Glioma - Retrospective Review.

Cureus

Irfan N, Samuel E, Rafi Ranjha F, Waheed A, Abu Bakar M, Usman S, Butt S, Rashid A, Yousaf I.
PMID: 33224664
Cureus. 2020 Oct 20;12(10):e11070. doi: 10.7759/cureus.11070.

Background The role of Procarbazine Lomustine and Vincristine (PCV) chemotherapy is already established in terms of improving survival in low-grade glioma (LGG). This improved survival has led to the increasing administration of PCV to LGG patients over the past...

Cite
Irfan N, Samuel E, Rafi Ranjha F, et al. Toxicity Profile of Procarbazine Lomustine and Vincristine Chemotherapy in Low-Grade Glioma - Retrospective Review. Cureus. 2020;12(10):e11070doi: 10.7759/cureus.11070.
Irfan, N., Samuel, E., Rafi Ranjha, F., Waheed, A., Abu Bakar, M., Usman, S., Butt, S., Rashid, A., & Yousaf, I. (2020). Toxicity Profile of Procarbazine Lomustine and Vincristine Chemotherapy in Low-Grade Glioma - Retrospective Review. Cureus, 12(10), e11070. https://doi.org/10.7759/cureus.11070
Irfan, Nabia, et al. "Toxicity Profile of Procarbazine Lomustine and Vincristine Chemotherapy in Low-Grade Glioma - Retrospective Review." Cureus vol. 12,10 (2020): e11070. doi: https://doi.org/10.7759/cureus.11070
Irfan N, Samuel E, Rafi Ranjha F, Waheed A, Abu Bakar M, Usman S, Butt S, Rashid A, Yousaf I. Toxicity Profile of Procarbazine Lomustine and Vincristine Chemotherapy in Low-Grade Glioma - Retrospective Review. Cureus. 2020 Oct 20;12(10):e11070. doi: 10.7759/cureus.11070. PMID: 33224664; PMCID: PMC7676953.
Copy Download .nbib Format: NLM
Cyclic Vomiting Syndrome in Children.

Frontiers in neurology

Raucci U, Borrelli O, Di Nardo G, Tambucci R, Pavone P, Salvatore S, Baldassarre ME, Cordelli DM, Falsaperla R, Felici E, Ferilli MAN, Grosso S, Mallardo S, Martinelli D, Quitadamo P, Pensabene L, Romano C, Savasta S, Spalice A, Strisciuglio C, Suppiej A, Valeriani M, Zenzeri L, Verrotti A, Staiano A, Villa MP, Ruggieri M, Striano P, Parisi P.
PMID: 33224097
Front Neurol. 2020 Nov 02;11:583425. doi: 10.3389/fneur.2020.583425. eCollection 2020.

Cyclic Vomiting Syndrome (CVS) is an underdiagnosed episodic syndrome characterized by frequent hospitalizations, multiple comorbidities, and poor quality of life. It is often misdiagnosed due to the unappreciated pattern of recurrence and lack of confirmatory testing. CVS mainly occurs...

Cite
Raucci U, Borrelli O, Di Nardo G, et al. Cyclic Vomiting Syndrome in Children. Front Neurol. 2020;11:583425doi: 10.3389/fneur.2020.583425.
Raucci, U., Borrelli, O., Di Nardo, G., Tambucci, R., Pavone, P., Salvatore, S., Baldassarre, M. E., Cordelli, D. M., Falsaperla, R., Felici, E., Ferilli, M. A. N., Grosso, S., Mallardo, S., Martinelli, D., Quitadamo, P., Pensabene, L., Romano, C., Savasta, S., Spalice, A., Strisciuglio, C., Suppiej, A., Valeriani, M., Zenzeri, L., Verrotti, A., Staiano, A., Villa, M. P., Ruggieri, M., Striano, P., & Parisi, P. (2020). Cyclic Vomiting Syndrome in Children. Frontiers in neurology, 11583425. https://doi.org/10.3389/fneur.2020.583425
Raucci, Umberto, et al. "Cyclic Vomiting Syndrome in Children." Frontiers in neurology vol. 11 (2020): 583425. doi: https://doi.org/10.3389/fneur.2020.583425
Raucci U, Borrelli O, Di Nardo G, Tambucci R, Pavone P, Salvatore S, Baldassarre ME, Cordelli DM, Falsaperla R, Felici E, Ferilli MAN, Grosso S, Mallardo S, Martinelli D, Quitadamo P, Pensabene L, Romano C, Savasta S, Spalice A, Strisciuglio C, Suppiej A, Valeriani M, Zenzeri L, Verrotti A, Staiano A, Villa MP, Ruggieri M, Striano P, Parisi P. Cyclic Vomiting Syndrome in Children. Front Neurol. 2020 Nov 02;11:583425. doi: 10.3389/fneur.2020.583425. eCollection 2020. PMID: 33224097; PMCID: PMC7667239.
Copy Download .nbib Format: NLM
Showing 793 to 804 of 808 entries